Axel Bolte
CHAIR
MOLECULAR BIOLOGY
Tanner Health System
Luxembourg
Biography
Since February 2017, Mr. Bolte has served as director, president and chief executive officer of Inozyme Pharma Inc., a private biotechnology company. Mr. Bolte also serves as a venture partner at HBM Partners AG, a provider of investment advisory services in the life sciences industry, where he previously served as an investment advisor from March 2003 until January 2017
Research Interest
BIOTECH
